Partnership Expansion Lucence's recent collaboration with Mayo Clinic and integration with Agilus Diagnostics highlight a strategic focus on expanding diagnostic reach and enhancing clinical utility, presenting opportunities to offer complementary technologies or services.
Innovative Testing The launch of LiquidHALLMARK ctDNA and ctRNA liquid biopsy tests demonstrates a commitment to cutting-edge diagnostic offerings, opening avenues to position advanced liquid biopsy solutions to healthcare providers seeking innovative cancer detection tools.
Regulatory & Coverage Obtaining a CPT PCLA code indicates improved reimbursement pathways, making it easier to pitch Lucence’s tests to hospitals and clinics looking for approved, reimbursable cancer diagnostics.
Market Presence Participation in major events such as ASCO and WCLC, combined with regional launches across the Pacific Northwest and Intermountain regions, suggests active outreach to key oncology and diagnostic markets for targeted sales efforts.
Funding & Growth With over US$80 million in funding and a revenue range of 100-250 million dollars, Lucence's robust financial backing underscores a strong growth trajectory, signaling opportunities for strategic partnerships or pilot programs with interested healthcare institutions.
Lucence uses 8 technology products and services including Power BI, NoSQL, PostgreSQL, and more. Explore Lucence's tech stack below.
| Lucence Email Formats | Percentage |
| First.Last@lucence.com | 48% |
| First.Middle@lucence.com | 2% |
| FirstMiddle.Last@lucence.com | 2% |
| First.Last@lucence.com | 48% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Lucence is a precision health company, using proprietary AI-powered liquid biopsy technology to detect cancers earlier when outcomes are better. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit www.lucence.com.
Company Overview
Funding & FinancialsLucence has raised a total of $73M of funding over 4 rounds. Their latest funding round was raised on Nov 20, 2019 in the amount of $20Mas a Series A.
Lucence's revenue is estimated to be in the range of $100M$250M
Funding & FinancialsLucence has raised a total of $73M of funding over 4 rounds. Their latest funding round was raised on Nov 20, 2019 in the amount of $20Mas a Series A.
Lucence's revenue is estimated to be in the range of $100M$250M
1-888-653-2347 
support@leadiq.com